GlassScriptPhysician profile
Kaushik C Modi
NPI 1700886132
$2,816.75
in general payments reported to CMS, 2019-2025
19 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,318 · 2020: $66.43 · 2022: $130 · 2023: $13.62 · 2024: $60.24 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,960.46 | 2019 | |
| Merck Sharp & Dohme LLC | $141.52 | 2019-2025 | Lagevrio, Verquvo |
| Edwards Lifesciences Corporation | $129.84 | 2022 | |
| Janssen Pharmaceuticals, INC | $123.47 | 2019-2020 | |
| Novo Nordisk INC | $75.07 | 2024-2025 | Ozempic |
| Exact Sciences Corporation | $73.46 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.36 | 2019 | |
| Amgen INC. | $42.54 | 2019-2023 | Repatha |
| Atricure, INC. | $35.89 | 2019 | |
| Ucb, INC. | $27.14 | 2019 | |
| Lilly USA, LLC | $19.50 | 2025 | Zepbound |
| Azurity Pharmaceuticals, INC. | $17.79 | 2025 | Edarbi |
| Astrazeneca Pharmaceuticals LP | $16.09 | 2025 | Wainua |
| Kowa Pharmaceuticals America, INC. | $15.00 | 2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $15.00 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $14.75 | 2025 | Prospera |
| Pfizer INC. | $14.21 | 2019 | |
| Redhill Biopharma INC. | $13.66 | 2020 | |
| Sanofi Pasteur INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaushik Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.